IR is defined as the impaired response of target tissues to insulin-mediated glucose disposal, which triggers compensatory hyperinsulinemia, leading to the development of MetS, type 2 DM, and other metabolic disorders, including cardiovascular disease and non-alcoholic fatty liver disease6,7. The gene discussed is INS; the disease is metabolic syndrome.